Login to Your Account



Week in Review


Monday, November 21, 2011

Financings

Adventrx Pharmaceuticals Inc. raised $17 million in a public offering of stock and warrants.

Agios Pharmaceuticals Inc. raised $78 million in a Series C financing.

Allena Pharmaceuticals Inc. raised $15 million in a Series A round for nonsystemic oral proteins.

Athersys Inc. entered a $20 million standby equity purchase agreement with Aspire Capital Fund LLC.

Cadence Pharmaceuticals Inc. is raising $71.25 million in a public stock offering.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription